Vitro Biopharma, Inc. Quarterly Liabilities and Equity in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Vitro Biopharma, Inc. quarterly Liabilities and Equity history and growth rate from Q3 2010 to Q2 2024.
  • Vitro Biopharma, Inc. Liabilities and Equity for the quarter ending July 31, 2024 was $6.81M, a 25.4% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.81M -$2.32M -25.4% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $7.09M -$1.06M -13% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $7.36M -$744K -9.18% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $8.34M -$231K -2.69% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $9.12M Jul 31, 2023 10-Q 2023-08-28
Q1 2023 $8.16M Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $8.11M Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $8.57M Oct 31, 2022 10-K 2024-01-29
Q3 2015 $116K +$10.5K +9.96% Oct 31, 2015 10-K 2016-09-22
Q2 2015 $118K +$2.24K +1.94% Jul 31, 2015 10-Q 2016-03-30
Q1 2015 $105K -$28.8K -21.5% Apr 30, 2015 10-Q 2016-01-22
Q4 2014 $98.7K -$40.1K -28.9% Jan 31, 2015 10-Q 2015-03-24
Q3 2014 $106K +$29.4K +38.6% Oct 31, 2014 10-K 2016-09-22
Q2 2014 $116K +$37.8K +48.5% Jul 31, 2014 10-Q 2014-09-22
Q1 2014 $134K +$58.6K +77.7% Apr 30, 2014 10-Q 2014-06-19
Q4 2013 $139K +$55K +65.7% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $76.2K -$9.01K -10.6% Oct 31, 2013 10-K 2015-02-13
Q2 2013 $77.9K -$8.81K -10.2% Jul 31, 2013 10-Q 2013-09-23
Q1 2013 $75.3K -$1.61K -2.09% Apr 30, 2013 10-Q 2013-06-18
Q4 2012 $83.8K +$2.6K +3.2% Jan 31, 2013 10-Q 2013-03-21
Q3 2012 $85.2K -$1.19K -1.38% Oct 31, 2012 10-K 2014-02-12
Q2 2012 $86.7K -$5.97K -6.44% Jul 31, 2012 10-Q/A 2012-10-17
Q1 2012 $77K Apr 30, 2012 10-Q/A 2012-06-22
Q4 2011 $81.2K Jan 31, 2012 10-Q 2012-03-21
Q3 2011 $86.4K -$29.7K -25.6% Oct 31, 2011 10-K 2013-02-12
Q2 2011 $92.7K Jul 31, 2011 10-Q/A 2011-10-12
Q3 2010 $116K Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.